BERTAGNIN, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 708
EU - Europa 103
AS - Asia 71
SA - Sud America 4
AF - Africa 3
Totale 889
Nazione #
US - Stati Uniti d'America 708
CN - Cina 63
IT - Italia 33
FI - Finlandia 14
IE - Irlanda 14
FR - Francia 13
DE - Germania 11
GB - Regno Unito 6
SE - Svezia 6
GH - Ghana 3
IN - India 3
UA - Ucraina 3
BR - Brasile 2
JP - Giappone 2
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 889
Città #
Fairfield 115
Ashburn 82
Chandler 79
Woodbridge 52
Cambridge 46
Seattle 46
Houston 40
Ann Arbor 30
Wilmington 26
Columbus 24
San Diego 20
Beijing 19
Dublin 14
Helsinki 14
Medford 11
Princeton 11
Padova 9
Roxbury 9
Des Moines 8
Washington 6
Guangzhou 5
Shanghai 5
Milan 4
Accra 3
Boardman 3
Falls Church 3
Kharkiv 3
Nanjing 3
Palermo 3
Pune 3
Americana 2
Borås 2
Camponogara 2
Dearborn 2
Fuzhou 2
Hefei 2
London 2
New York 2
Agordo 1
Berlin 1
Cartagena 1
Chicago 1
Cochabamba 1
Copenhagen 1
Frankfurt am Main 1
Hangzhou 1
Hanover 1
Islington 1
Jiaxing 1
Kuala Lumpur 1
Kunming 1
Nanchang 1
Norwalk 1
Ogden 1
San Jose 1
Santa Clara 1
Shenyang 1
Strasbourg 1
Taizhou 1
Turin 1
Vientiane 1
Wuhan 1
Zhengzhou 1
Totale 737
Nome #
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 130
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant 111
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant 108
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 98
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 97
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 80
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity 58
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 56
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 53
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 31
Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability 30
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant 20
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 18
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 14
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties 12
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 2
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation 1
Totale 919
Categoria #
all - tutte 4.282
article - articoli 4.282
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 8 14 13
2019/2020165 10 11 3 12 16 14 21 23 23 14 13 5
2020/2021136 4 8 2 7 2 4 1 9 28 5 33 33
2021/2022201 4 9 20 26 17 17 11 21 3 12 24 37
2022/2023198 28 17 8 16 29 39 0 12 19 12 11 7
2023/2024179 2 16 41 11 26 21 29 21 2 10 0 0
Totale 919